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Anemia is highly prevalent, especially in older individuals. In select-ed populations, anemia has been reported to be associated withimpaired survival and health-related quality of life. However, data
on this impact in the general population are rare. Furthermore, discus-
sions on the optimal definition of anemia have not been conclusive. We
investigated these issues using survival data, scores from a health-related
quality of life questionnaire (RAND-36), and hemoglobin concentration
from 138670 subjects, aged 18-93 years, participating in the Lifelines
cohort. Anemia was defined according to World Health Organization
criteria and was further subclassified in participants over 60 years old.
Anemia was present in 5510 (4.0%) of all 138670 subjects and 516
(2.8%) in the 18667 individuals older than 60 years. Anemia had no
impact on overall survival and limited impact on health-related quality
of life in individuals less than 60 years old. In contrast, in individuals over
60 years old anemia significantly impaired overall survival and health-
related quality of life. The lower health-related quality of life was mainly
observed in subscales representing physical functioning. Although con-
sensus on the subclassification of anemia is lacking, our data suggest that
particularly anemia of chronic inflammation was associated with worse
overall survival and decreased health-related quality of life. Multivariate
models confirmed that anemia was an independent risk factor for
decreased health-related quality of life in older individuals. Finally,
women with a hemoglobin concentration between 12.0-13.0 g/dL (con-
sidered anemia in men, but not in women) experienced a significantly
lower health-related quality of life. This large, prospective, population-
based study indicates that anemia is associated with worse overall sur-
vival and health-related quality of life in older individuals, but not in
younger individuals. The findings of this study challenge the definition
of anemia in women over 60 years old, and suggest that the optimal def-
inition of anemia, in the perspective of health-related quality of life, in
women over 60 years old should be altered to a hemoglobin concentra-
tion below 13.0 g/dL (8.0 mmol/L), which is comparable to that in men.
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ABSTRACT
Introduction
Anemia, according to the World Health Organization
(WHO) criteria, is defined as a hemoglobin concentration
<13.0 g/dL (8.0 mmol/L) in adult men and <12.0 g/dL (7.5
mmol/L) in adult, non-pregnant women. Anemia affects
nearly 25% of the world population.1,2 In developed coun-
tries, anemia is one of the most frequent conditions in older
individuals, with a presumed prevalence of over 10% indi-
viduals who are 65 years or older in selected populations.3,4
More than half of anemic older individuals can be diagnosed
with nutritional deficiencies or have anemia of chronic
inflammation (ACI). The etiology of anemia remains
unknown in about one-third of the older population.4 In
older individuals the presence of anemia, even mild anemia,
is associated with an increased risk of falls,5 decreased phys-
ical performance,6 longer and more frequent stays in hospi-
tal,7-9 and increased mortality.7,9,10 Suggestions to raise the
hemoglobin thresholds for the definition of anemia in older
individuals have been made in several studies.11,12
The impact of anemia on health-related quality of life
(HRQoL) has been studied in different populations of
patients, including patients with chronic kidney dis-
ease,13 chronic obstructive pulmonary disease,14 cancer15
and heart failure.16 In these studies, anemia was reported
to be associated with a reduced HRQoL. However, little
research has been done on this potential association in
community-dwelling populations. Better understanding
of the impact of anemia on HRQoL in a community-
dwelling general population is therefore essential and
could provide critical entry points for interventions that
affect anemia, especially in older individuals. 
In this study, we investigated the association between
anemia and survival, and between anemia and HRQoL.
In addition, we used this association to evaluate the def-
inition of anemia, considering the impact of age and gen-
der on this association in the large community-dwelling
population from the Lifelines cohort.17
Methods
Subjects
In this study we used data from 138670 subjects participating in
the Lifelines cohort study. Data from quality of life questionnaires
and on hemoglobin concentration were available for these sub-
jects. Lifelines is a multidisciplinary, prospective, population-based
cohort study examining, in a unique three-generation design, the
health and health-related behaviors of persons living in the north
of the Netherlands. It has been shown that the Lifelines cohort is
representative of the population of the northern part of the
Netherlands.18 The local ethics committee approved the research
protocol and informed consent was signed by every participant.
Health-related quality of life
HRQoL was measured using the RAND 36-Item Health
Survey.19 Since HRQoL scores are not normally distributed, for
each subscale we defined a sex-specific and age-specific cut-off
point at the 25th percentile of the non-anemic Lifelines population.
Participants with a score lower than 25th percentile were consid-
ered to have an abnormally low score for that specific subscale.
Survival
All participants were followed from the moment of their
inclusion in the Lifelines cohort until death or up to May 2018
(maximum follow-up 138 months, median 79 months).
Information on participants’ deaths was obtained from the
municipal personal records database.
Definition of anemia and classification into subtypes
of anemia
In accordance with the WHO criteria, anemia was defined as
a hemoglobin concentration <13.0 g/dL (8.0 mmol/L) in adult
men and <12.0 g/dL (7.5 mmol/L) in adult, non-pregnant
women.20 In anemic subjects older than 60 years of age addi-
tional biochemical tests were performed, using stored plasma,
to determine the type of anemia: anemia due to nutritional defi-
ciency, ACI or unexplained anemia. There is no worldwide
accepted classification into subtypes of anemia. Reference val-
ues were taken from the University Medical Center Groningen
or from published literature, as indicated. Iron deficiency was
considered present if the participant had two or three of the fol-
lowing criteria: serum ferritin concentration <30 mg/L, transfer-
rin saturation rate <16% or hepcidin concentration <0.5
nmol/L.21-23 Transferrin saturation was calculated by dividing
serum iron by total iron-binding capacity [transferrin (g/L)x25].
Folate deficiency was defined as a serum folate level <9.8
nmol/L. Vitamin B12 deficiency was defined as a serum methyl-
malonic acid concentration >340 nmol/L, if the estimated
glomerular filtration was >30 mL/min (because methylmalonic
acid levels may be elevated in people with severely impaired
renal function24). If there was no evidence of nutrient deficiency,
subjects with anemia were evaluated for other causes. Subjects
were classified as having anemia related to chronic renal disease
if the estimated glomerular filtration rate was <30 mL/min. The
Chronic Kidney Disease-Epidemiology Collaboration (CDK-
EPI) formula was used to calculate the estimated glomerular fil-
tration rate. ACI was defined as present if the participant had (i)
a C-reactive protein concentration >5.0 mg/L or an absolute
number of leukocytes >10x109/L and (ii) two or more of the fol-
lowing criteria: transferrin saturation rate <16%, serum ferritin
concentration >100 mg/L, serum iron <10 mmol/L and hepcidin
>14.7 nmol/L in men or hepcidin>15.6 nmol/L in women.25,26 If
subjects with anemia could not be classified into any of these
categories, they were considered, by exclusion, to have unex-
plained anemia. 
Details of the Lifelines cohort, clinical examination, biochem-
ical measurements, RAND 36-Item Health Survey and data
description and statistical analysis are provided in the Online
Supplementary Data.
Results
Relevant baseline characteristics are shown in Table 1
for anemic and  non-anemic participants from the popu-
lation-based Lifelines cohort. In total 551 men and 4959
women met the WHO criteria for anemia. The overall
prevalence of anemia was 4.0% (Figure 1A). The preva-
lence of anemia in women was highest (about 8%) in the
age cohort 40-49 years and showed a second peak of
about 4% at an older age (older than 70 years). In con-
trast, the prevalence of anemia in men gradually
increased with age, with a peak of about 5% in older age
(older than 70 years). In the population of individuals 60
years of age and older the overall prevalence of anemia
was 2.8%, with a prevalence of 2.7% in men and 3.0%
in women. The distribution of the hemoglobin concen-
tration according to age is shown in Online Supplementary
Figure S2A,C. In men, unlike in women, the mean hemo-
Anemia, survival and health-related quality of life
haematologica | 2019; 104(3) 469
globin concentration decreased with age (Online
Supplementary Figure S2B,D). Over 90% of the anemic
individuals had mild anemia [>10 g/dL, (> 6.2 mmol/L)].
In individuals younger than 60 years the presence of ane-
mia did not have any impact on overall survival (Figure
1B). In contrast, the overall survival of anemic individuals
older than 60 years was significantly lower than that of
non-anemic individuals older than 60 years (Figures 1C). 
The mean of the total HRQoL score was significantly
lower in anemic individuals in all age groups than in non-
H.J.C.M. Wouters et al.
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Table 1. Baseline characteristics of the study cohort.
                                                                           Anemic individuals                                      Non-anemic individuals                                   P-value
                                                                                  (N=5510)                                                      (N=133160)                                                  
Men/women                                                                 551 (10.0)/4959 (90.0)                                            57283 (43.0)/75877 (57.0)                                           <0.001
Age (years)                                                                             43.4 ± 11.9                                                                   44.3 ± 12.7                                                        <0.001
Body mass index (kg/m2)                                               24.2 (22.1 - 27.2)                                                         25.4 (23.1 - 28.2)                                                   <0.001
Creatinine (µmol/L)                                                                69 ± 18                                                                         74 ± 13                                                           <0.001
Estimated glomerular filtration rate (mL/min)               98 ± 17                                                                          97± 15                                                             0.003
HbA1c (%)                                                                                5.6 ± 0.5                                                                       5.5 ± 0.4                                                          <0.001
Glucose (mmol/L)                                                                  4.9 ± 0.8                                                                       5.0 ± 0.8                                                          <0.001
Leukocytes (109/L)                                                                  5.6 ± 1.7                                                                       6.1 ± 1.8                                                          <0.001
Platelets (109/L)                                                                      278 ± 70                                                                       249 ± 56                                                          <0.001
Number of medications                                                        2 (1 – 3)                                                                       2 (1 – 3)                                                          <0.001
Multiple drug use                                                                  712 (12.9)                                                                   12360 (9.3)                                                        <0.001
Non-smokers/former                                     3048 (55.3)/1754 (31.8)/708 (12.8)                     62228 (46.7)/42411 (31.8)/28521 (21.4)                               <0.001
smokers/current smokers
Data are given as mean ± standard deviation, median (interquartile range) when not normally distributed, or n (%). HbA1c: glycated hemoglobin.
Figure 1. Prevalence of anemia and overall survival in individuals younger and older than 60 years. (A) The prevalence of anemia as a function of sex and age. (B)
Overall survival of non-anemic and anemic individuals younger than 60 years. (C) Overall survival of non-anemic and anemic individuals older than 60 years. 
anemic individuals (Online Supplementary Figure S3A). At
a younger age the mean difference was relatively small,
but after the age of 60 years this difference in mean
HRQoL increased substantially. Because HRQoL scores
are not normally distributed, we also studied the per-
centage of individuals with a HRQoL score below a cut-
off value. This analysis revealed that the percentage of
individuals with a total score below the 25th percentile
was significantly higher among the group of individuals
over 60 years old (Online Supplementary Figure S3B).
Older individuals had a significantly lower mean HRQoL
in the subscales physical functioning, social functioning,
physical role functioning, emotional role functioning,
vitality, bodily pain and general health (Online
Supplementary Figure S4). Moreover, a significantly larger
proportion of anemic subjects older than 70 years had a
score below the cut-off value, indicating a poor score, in
six of the eight subscales: physical functioning (40% ver-
sus 25%), social functioning (42% versus 33%), physical
role functioning (35% versus 23%), vitality (36% versus
27%), bodily pain (45% versus 32%) and general health
(42% versus 32%). In subjects between 60-70 years old
there was a difference in the subscales physical function-
ing (36% versus 27%) and physical role functioning (29%
versus 21%) (Figure 2). Between 18-60 years no signifi-
cant differences were observed when comparing per-
centages of individuals with a HRQoL score below the
cut-off value. Finally, we used multivariate logistic
Anemia, survival and health-related quality of life
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Figure 2. Percentages of individuals, divided according to age group, with scores below the sex- and age-specific cut-off values for the different subscales of the
RAND-36 health survey. An asterisk indicates a significantly (P-value <0.01) larger percentage below the sex- and age-specific cut-off value in anemic individuals
compared with non-anemic individuals. PF: physical functioning; SF: social functioning; RF: physical role functioning; RE: emotional role functioning; MH: mental
health; VT: vitality; BP: bodily pain; GH: general health.
regression analysis to investigate whether anemia was an
independent risk factor for HRQoL. This analysis
showed that anemia, adjusted for body mass index,
being a current smoker, multiple drug use, educational
level and living situation independently increased the
risk of having a lower total HRQoL (OR 1.28; 95% CI:
1.00 – 1.64; P=0.046). 
Since anemia had a particular impact on overall sur-
vival and HRQoL in subjects older than 60 years within
the Lifelines cohort, the type of anemia in these individ-
uals was further characterized (see the Methods section).
In total 174 (35.0%) subjects were classified as having
nutrient deficiency anemia, 81 (16.3%) as having ACI,
and 242 (48.7%) as having unexplained anemia (Online
Supplementary Table S1). Compared with individuals
from the general population, a significantly larger pro-
portion of individuals with ACI had a HRQoL score
lower than the cut-off value in seven of the eight sub-
scales (all except mental health) (Table 2). Nutrient defi-
ciency anemia was associated with a significantly lower
score in only one subscale (physical functioning).
Individuals with unexplained anemia had a significantly
lower score in the subscale bodily pain. These results
were more explicit in men than in women (Online
Supplementary Tables S2 and S3). In order to determine
which type of anemia was an independent risk factor for
HRQoL in individuals older than 60 years, we performed
logistic regression analysis in individuals older than 60
years (Table 3 and Online Supplementary Table S4). After
adjusting for body mass index, being a current smoking,
multiple drug use, educational level and living situation,
ACI was associated with a higher risk of having a score
below the cut-off in all seven subscales which were
affected by anemia (i.e. all subscales except mental
health) (Table 3). Overall survival was significantly lower
in individuals with ACI than in those with nutrient defi-
ciency anemia or unexplained anemia (Figure 3). 
Although the difference between the median values of
the hemoglobin concentration decreased during aging,
(Online Supplementary Figure S5), the definition of anemia
is based on hemoglobin concentrations obtained in
younger adults. Consequently, there are persistent dis-
cussions regarding whether the definition of anemia in
older individuals is appropriate or should be corrected
using a higher hemoglobin threshold. Because of the
clear correlation between anemia in individuals older
than 60 years and survival and HRQoL, we used these
associations to reassess the definition of anemia in indi-
viduals older than 60 years. We assumed that anemia
should be considered in the case that a certain hemoglo-
bin level was associated with a significant (negative)
impact on HRQoL. Logistic regression was used to
model the relationship between hemoglobin concentra-
tion and total HRQoL in both men and women. These
analyses revealed that men older than 60 years with a
hemoglobin concentration between 13.0-13.7 g/dL (8.0-
8.5 mmol/L) (just above the current WHO defined
threshold) did not have a lower HRQoL compared with
men with a hemoglobin concentration >13.7 g/dL (8.5
mmol/L), suggesting that the current threshold which
defines anemia in men is appropriate. However, when
specifically comparing women older than 60 years with
a hemoglobin concentration between 12.0-13.0 g/dL
(7.5-8.0 mmol/L) (considered anemic for men but not
anemic for women according to the current WHO defi-
nition), this group had a lower HRQoL than that of
women with a hemoglobin concentration >13.0 g/dL (8.0
mmol/L). These data strongly suggest that the optimal
definition of anemia for women older than 60 years
should be a hemoglobin concentration <13.0 g/dL (8.0
mmol/L) (Figure 4). So, in the case that HRQoL is used to
define anemia, there would be no difference in the defi-
nition between older men and women. Due to the limit-
ed number of deaths among groups of individuals divid-
H.J.C.M. Wouters et al.
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Table 2. Percentage of individuals older than 60 years with anemia with HRQoL below the sex- and age-specific cut-off value for the different
HRQoL subscales as a function of their type of anemia.
                                                       General population                         Nutrient deficiency                       Anemia of chronic                  Unexplained 
                                                      older than 60 years                                   anemia                                     inflammation                          anemia
                                                             (N=18152)                                         (N=174)                                         (N=81)                              (N=242)
Physical functioning                                     4869 (26.8)                                                67 (38.5)*                                             40 (49.4)*                                 78 (32.2)
                                                                                                                                                 P <0.001                                                 P<0.001                                            
Social functioning                                         5482 (30.2)                                                 53 (30.5)                                              41 (50.6)*                                 85 (26.0)
                                                                                                                                                                                                                  P<0.001                                            
Physical role functioning                            3820 (21.0)                                                 49 (28.2)                                              41 (50.6)*                                 63 (26.0)
                                                                                                                                                                                                                  P<0.001                                            
Emotional role functioning                        1936 (10.7)                                                 20 (11.5)                                              17 (21.0)*                                 30 (12.4)
                                                                                                                                                                                                                  P=0.003                                            
Mental health                                                5216 (28.7)                                                 42 (24.1)                                                26 (32.1)                                   72 (29.8)
Vitality                                                              4820 (26.5)                                                 49 (28.2)                                              39 (47.0)*                                 75 (31.0)
                                                                                                                                                                                                                 P<0.001
Bodily pain                                                      5618 (30.9)                                                 60 (34.5)                                              40 (49.4)*                                95 (39.3)*
                                                                                                                                                                                                                 P<0.001                                    P=0.006
General health                                              5104 (28.1)                                                 60 (34.5)                                              40 (49.4)*                                 79 (32.6)
                                                                                                                                                                                                                  P<0.001                                            
Data are given as n (%) below the sex- and age-specific cut-off value for the different HRQoL subscales.* P-value <0.01 between individuals from the non-anemic group of the
general population and individuals with the given type of anemia.
ed according to the various intervals of hemoglobin con-
centration, survival could not be used to model the opti-
mal definition of anemia. 
Discussion
In this study we observed that anemia is associated
with worse overall survival and is an independent risk
factor for HRQoL in individuals older than 60 years, in
contrast to younger individuals. Although consensus on
the subclassification of anemia is lacking, our data sug-
gest that particularly ACI was an independent risk factor
for HRQoL in subscales representing physical function-
ing. Furthermore, we observed that women (but not
men) older than 60 years with a hemoglobin concentra-
tion in the lower normal WHO range experienced
decreased HRQoL. This suggests that the definition of
anemia in women older than 60 years should be altered
to a hemoglobin concentration <13.0 g/dL (8.0 mmol/L),
which is comparable to the definition of anemia in men.
The prevalence of anemia according to the WHO crite-
ria was 4.0% in the whole cohort and 2.8% among sub-
jects older than 60 years, which is consistent with the
findings of population-based studies from Sweden (3.8%
in patients 44 - 73 years old)27 and Germany  (3.2% in
subjects 45-75 years old28 and 6.9% in subjects over 65
years old29). However, the prevalence of anemia in older
individuals in our community-dwelling population was
remarkably lower than that found in previous studies.3,4,30
A possible explanation for this discrepancy could be a
participation bias in the Lifelines cohort, although earlier
observations showed that the Lifelines study population
is representative of the general population, with a low
risk of selection.18 The relatively low prevalence of ane-
mia in older individuals could also be related to the high
quality and accessibility of the general health system
nowadays, especially for older individuals. Furthermore,
the prevalence of anemia and the types of anemia might
differ according to race and geographical area.2,4
Anemia did not have an impact on survival in individ-
uals younger than 60 years. In contrast, among individu-
als older than 60 years, anemic subjects had a significant-
ly decreased survival. The decreased survival in older
anemic individuals is in accordance with that in multiple
previous studies.7,9,10 In our study there was increased
mortality in older individuals with ACI: this finding is
partly in line with the findings of a study by Willems et
al. who reported increased mortality in subjects with
nutrient deficiency anemia and ACI, but not in those
with unexplained anemia.31
Since an aging population results in an increased preva-
lence of anemia, an understanding of the association
between anemia and HRQoL is important. Remarkably,
only a few, relatively small studies of community-
dwelling populations have described this association. In
a study of 717 subjects, Lucca et al. showed, after adjust-
ment for a large number of demographic and clinical con-
founders, that anemia in elderly Italians (65 - 84 years
old) was significantly associated with lower disease-spe-
cific QoL, measured with the Functional Assessment of
Cancer Therapy-Anemia.32 Thein et al. studied an
American cohort of 328 individuals and showed that
anemia in subjects older than 65 years was independent-
ly associated with impairments in multiple subscales of
HRQoL (measured with the Short Form-36), especially in
measures of functional limitation.33 Bang et al. also found
that anemia was associated with physical impairment in
695 Korean individuals older than 65 years.34 Our data, in
an unprecedented large cohort, confirms the relationship
between anemia and HRQoL in older individuals (but
not in younger individuals). 
There is no worldwide accepted classification into sub-
types of anemia. To be able to study the subtypes, we
based our criteria on literature or reference values from
the local laboratory. In addition to those criteria, we also
analyzed the data with different classification criteria
(see Online Supplementary Data for definitions). Although
misclassification within the various subtypes of anemia
cannot be excluded, our data suggest that the impact of
anemia on HRQoL is mainly present in individuals with
ACI (Online Supplementary Tables S5 and S6). The patho-
physiology of ACI is multifactorial, including increased
levels of inflammatory cytokines that lead to altered iron
metabolism, with a key role for the iron regulatory pep-
tide hormone hepcidin.35,36 Indeed, elevated levels of
inflammatory markers, which are found in older anemic
individuals, have been shown to be associated with
physical disability.37,38 Our observation that anemia main-
ly affects HRQoL of subjects with ACI is supported by
studies showing that erythropoiesis-stimulating agents
Anemia, survival and health-related quality of life
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Table 3. Risk of having a lower score than the (age- and sex- specific) 25th per-
centile cut-off due to anemia per HRQoL subscale among individuals older than
60 years.
HRQoL subscale     Type of anemia                                          Odds ratio (95% CI)
Physical                   Nutritional deficiency anemia                        1.16 (0.75 – 1.79)
functioning           Anemia of chronic inflammation               3.30 (1.76 – 6.21)
                                                                                                                         **P<0.001
                                      Unexplained anemia                                         1.04 (0.74 – 1.48)
Social                       Nutritional deficiency anemia                        0.89 (0.58 - 1.35)
functioning            Anemia of chronic inflammation               2.39 (1.32 – 4.31)
                                                                                                                        **P =0.004
                                      Unexplained anemia                                         1.04 (0.75 - 1.44)
Physical role        Nutritional deficiency anemia                        1.15 (0.74 – 1.78)
functioning            Anemia of chronic inflammation                3.75 (2.05- 6.83)
                                                                                                                         **P<0.001
                                      Unexplained anemia                                         1.03 (0.72 - 1.48)
Emotional role    Nutritional deficiency anemia                        0.89 (0.49 – 1.59)
functioning            Anemia of chronic inflammation               2.53 (1.31 – 4.90)
                                                                                                                         **P=0.006
                                      Unexplained anemia                                         1.04 (0.66 – 1.65)
Vitality                      Nutritional deficiency anemia                        0.92 (0.60 - 1.42)
                                      Anemia of chronic inflammation               2.89 (1.59 – 5.24)
                                                                                                                         **P<0.001
                                      Unexplained anemia                                         1.13 (0.81 - 1.57)
Bodily pain             Nutritional deficiency anemia                        0.96 (0.63 - 1.45)
                                      Anemia of chronic inflammation               1.84 (1.02 – 3.33)
                                                                                                                            *P=0.04
                                      Unexplained anemia                                         1.16 (0.84 – 1.60)
General health    Nutritional deficiency anemia                        0.87 (0.57 - 1.34)
                                      Anemia of chronic inflammation               2.44 (1.33 – 4.45)
                                                                                                                        **P =0.004
                                      Unexplained anemia                                         0.99 (0.71 – 1.38)
Adjusted for body mass index, smoking status, multiple drug use, educational level and living sit-
uation. Data are shown as odds ratio and 95% confidence interval (95% CI). **P-value <0.01; *P-
value <0.05.
have an impact on the HRQoL of patients with cancer,
HIV/AIDS and chronic kidney disease.39 In older individ-
uals a positive effect of erythropoiesis-stimulating agents
on QoL has been shown in patients with chronic kidney
disease,40 and chemotherapy-induced anemia.41 In one
randomized, blinded, placebo-controlled trial in predom-
inantly African-American elderly women with ACI or
unexplained anemia an increase of the hemoglobin con-
centration by 2 g/dL led to improvements in QoL as
measured by the Functional Assessment of Chronic
Illness Therapy instrument.42
The most pronounced association between HRQoL
and anemia was observed in older individuals and in sub-
scales related to physical health. This suggests that
younger individuals can compensate better for the phys-
ical consequences of anemia, limiting the impact of ane-
mia on their HRQoL. For older individuals these com-
pensatory mechanisms might be limited compared to
those in younger persons. The ability to engage in phys-
ical activities is known to be important for maintaining
QoL in older persons.43,44
In this study we defined anemia according to the
WHO criteria, which define anemia as a hemoglobin
concentration <13.0 g/dL (8.0 mmol/L) in adult men and
<12.0 g/dL (7.5 mmol/L) in adult, non-pregnant women.
This is the most commonly used definition of anemia,
but the use of this definition in older/elderly populations
has been criticized.11,12 The WHO criteria were derived
from a small study population of healthy, young partici-
pants nearly 50 years ago.20 Based on data from two large
American databases, Beutler et al. proposed new, slightly
higher cut-offs for white women older than 50 years and
white men older than 60 years.12
Although the different distributions of median hemo-
globin concentration between men and women (in gen-
eral and in older individuals) suggest that it is ‘logic’ to
use different definitions of anemia in men and women,
our data raise doubts about this logic. Indeed, HRQoL
data from our study suggest that the definition of anemia
in men – a hemoglobin concentration <13.0 g/dL (8.0
mmol/L) – should also be applied for women older than
60 years. Apparently, the hemoglobin values which start
to hamper (physical) functioning do not differ between
older men and women. We were not able to study the
optimal definition of anemia in perspective of mortality
because of the limited number of deaths in our cohort.
Martinsson et al. observed an increased mortality defin-
ing anemia as <14.0 g/dL (8.7 mmol/L) in men and <13.0
g/dL (8.0 mmol/L) in women.27 A recent, large study
assessing the effect of hemoglobin concentrations on car-
diovascular and all-cause mortality in nearly 300,000 par-
ticipants showed that men with a hemoglobin concen-
tration in the lower normal range had a higher risk of
mortality whereas this was not observed in women.45 
Our study has some strengths and limitations. It is the
first study to investigate the possible effect of anemia on
HRQoL in individuals of all ages in a very large cohort
from the general population. Additionally, we used infor-
mation on HRQoL from a large number of participants
with a wide range of age, socio-economic status and co-
morbidities. All subjects were uniformly characterized
and were not aware of hemoglobin status when filling
out the questionnaires, preventing the outcome of the
questionnaire from being affected by the knowledge of a
diagnosis of anemia. 
Several potential limitations should be acknowledged.
As mentioned earlier, the subtypes of anemia might have
been misclassified due to a lack of clear classification cri-
teria. Since this is a cross-sectional study, the analyses do
not provide information about causality, for example for
the fact that despite lower median hemoglobin concen-
trations in older women than in older men, the impact of
anemia on HRQoL occurred at the same hemoglobin
concentration. Additionally, given the observational
H.J.C.M. Wouters et al.
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Figure 3. Kaplan-Meier curves of survival of indi-
viduals with different types of anemia.
nature of the study, it was not possible to exclude the
role of unknown or unmeasured confounding variables.
A third limitation is that HRQoL was measured with the
RAND-36 questionnaire, which is a generic health status
questionnaire and not specifically developed to measure
QoL in anemic individuals. Finally, it is possible that the
results were influenced by volunteer bias.  
This study indicates that anemia is associated with
decreased survival and HRQoL, especially that concern-
ing physical health, in individuals older than 60 years.
After adjusting for confounding variables the impact of
anemia was particularly present in individuals with ACI.
These results suggest that older individuals might benefit
from treatment to increase their hemoglobin values.
Furthermore, this study challenges the sex-dependent
definition of anemia in individuals older than 60 years,
and suggests that in both men and women older than 60
years, the definition currently used in men [hemoglobin
concentration <13.0 g/dL (8.0 mmol/L)] could be applied
in perspective of HRQoL.
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